Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

PaperCitations, authors & open-access status

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 305 citations, 2012 year and closed oa status.

305
Citations
2012
Year
closed
OA Status

Related on ScholarIQ

Batia Weiss
Author
Clinical Gastroenterology and Hepatology
Journal
Inflammatory Bowel Disease
Topic
Inflammatory Bowel Disease
Topic
Immunodeficiency and Autoimmune Disorders
Topic
Microscopic Colitis
Topic
470M+ articles · free account